Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial - Byrd, JC; Hillmen, P; Ghia, P (J Clin Oncol, 2021)
et al.